Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00759_DB01164_nanopub.RAS9oPXlfoQRPu6l-juqR0x2EPrbuVKKMkWVSMP_eyeEQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00759_DB01164 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00759_DB01164 label "DDI between Tetracycline and Calcium Chloride - Calcium salts such as calcium chloride may decrease the serum concentration of tetracycline derivatives such as tetracycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives. [drugbank_resource:DB00759_DB01164]" assertion.
- drugbank_resource:DB00759_DB01164 identifier "drugbank_resource:DB00759_DB01164" assertion.
- drugbank_resource:DB00759_DB01164 title "DDI between Tetracycline and Calcium Chloride - Calcium salts such as calcium chloride may decrease the serum concentration of tetracycline derivatives such as tetracycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives." assertion.
- drugbank:DB01164 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00759_DB01164 assertion.
- drugbank:DB00759 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00759_DB01164 assertion.